I7379

Imipramin -hydrochlorid

≥99% (TLC), powder, antidepressant

• Synonym(e): 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepin-5-propanamin -hydrochlorid, 5-[3-(Dimethylamino)-propyl]-10,11-dihydro-5H-dibenz[b,f]azepin -hydrochlorid
• Empirische Formel (Hill-System): C₁₉H₂₄N₂ · HCl
• CAS-Nummer: 113-52-0
• Molekulargewicht: 316.87
• EG-Nummer: 204-030-7
• MDL-Nummer: MFCD00012669
• UNSPSC-Code: 12352116
• PubChem Substanz-ID: 24278097
• NACRES: NA.77

Eigenschaften

• product name: Imipramin -hydrochlorid, ≥99% (TLC)
• Qualitätsniveau: 200
• Assay: ≥99% (TLC)
• Form: powder
• Farbe: white
• Löslichkeit: H₂O: 50 mg/mL
• Ersteller: Novartis
• SMILES String: Cl[H].CN(C)CCCN1c2ccccc2CCc3ccccc13
• InChI: 1S/C19H24N2.ClH/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21;/h3-6,8-11H,7,12-15H2,1-2H3;1H
• InChIKey: XZZXIYZZBJDEEP-UHFFFAOYSA-N
• Angaben zum Gen: human ... HTR1A(3350) , HTR1B(3351) , HTR1D(3352) , HTR1E(3354) , HTR1F(3355) , HTR2A(3356) , HTR2B(3357) , HTR2C(3358) , HTR3A(3359) , HTR3B(9177) , HTR3C(170572) , HTR3D(200909) , HTR3E(285242) , HTR4(3360) , HTR5A(3361) , HTR5B(645694) , HTR6(3362) , HTR7(3363) , SLC6A2(6530) , SLC6A4(6532)

Beschreibung

Allgemeine Beschreibung

Imipramine is a tricyclic antidepressant. It has a half-life of 6 to 20 hours. Imipramine is made up of a tricyclic nucleus, that consists of two phenyl rings and a central cycloheptadien ring.

Anwendung

Imipramine hydrochloride has been used:

• as a non- selective serotonin reuptake inhibitor (SSRI) tricyclic anti-depressant (DD-IMI) to treat animals
• to investigate its interaction with insulin in aqueous solution
• to abolish the ability of internalized lipoproteins to stimulate cholesteryl esterification

Biochem./physiol. Wirkung

Tricyclisches Antidepressivum; hemmt die Serotonin- und Noradrenalin-Transporter mit K_is von 7.7 nM bzw. 67 nM. Hat wenig Einfluss auf Dopamin-Transporter (K_i = 25 μM).

Leistungsmerkmale und Vorteile

This compound is featured on the Biogenic Amine Transporters and Chloride Channels pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS06
• Signalwort: Danger
• H-Sätze: H300
• P-Sätze: P264 - P270 - P301 + P310 - P405 - P501
• Gefahreneinstufungen: Acute Tox. 2 Oral
• Lagerklassenschlüssel: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• WGK: WGK 1
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable